This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3tl5

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: '''Unreleased structure''' The entry 3tl5 is ON HOLD Authors: Murray, J.M., Wiesmann, C. Description: Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphati...)
m (Protected "3tl5" [edit=sysop:move=sysop])

Revision as of 05:49, 7 September 2011

Unreleased structure

The entry 3tl5 is ON HOLD

Authors: Murray, J.M., Wiesmann, C.

Description: Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools